Rhumbline Advisers Deciphera Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$13.58 - $17.36 $26,114 - $33,383	1,923 Added 2.38%	82,708 $1.3 Million
Q4 2023 Feb 08, 2024	SELL	$10.11 - $16.54 $101 - $165	-10 Reduced 0.01%	80,785 $1.3 Million
Q3 2023 Nov 09, 2023	BUY	$12.46 - $15.48 $5,719 - $7,105	459 Added 0.57%	80,795 $1.03 Million
Q2 2023 Aug 08, 2023	BUY	$13.28 - $15.96 $40,902 - $49,156	3,080 Added 3.99%	80,336 $1.13 Million
Q1 2023 May 11, 2023	BUY	$14.26 - $22.1 $140,175 - $217,243	9,830 Added 14.58%	77,256 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $30,739 - $39,412	2,070 Added 3.17%	67,426 $1.11 Million
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $58,037 - $94,838	4,688 Added 7.73%	65,356 $1.21 Million
Q2 2022 Aug 11, 2022	BUY	$9.11 - $13.98 $154,742 - $237,464	16,986 Added 38.89%	60,668 $798,000
Q1 2022 May 12, 2022	BUY	$6.87 - $11.11 $2,844 - $4,599	414 Added 0.96%	43,682 $405,000
Q4 2021 Feb 10, 2022	SELL	$7.7 - $37.13 $7,969 - $38,429	-1,035 Reduced 2.34%	43,268 $423,000
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $32,466 - $45,583	1,227 Added 2.85%	44,303 $1.51 Million
Q2 2021 Aug 05, 2021	SELL	$32.73 - $47.95 $22,190 - $32,510	-678 Reduced 1.55%	43,076 $1.58 Million
Q1 2021 May 06, 2021	SELL	$40.39 - $56.73 $154,895 - $217,559	-3,835 Reduced 8.06%	43,754 $1.96 Million
Q4 2020 Feb 10, 2021	BUY	$51.77 - $66.18 $43,538 - $55,657	841 Added 1.8%	47,589 $2.72 Million
Q3 2020 Nov 12, 2020	SELL	$43.8 - $58.16 $462,527 - $614,169	-10,560 Reduced 18.43%	46,748 $2.4 Million
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $1.06 Million - $1.85 Million	28,507 Added 98.98%	57,308 $3.42 Million
Q1 2020 May 06, 2020	BUY	$33.63 - $69.4 $86,395 - $178,288	2,569 Added 9.79%	28,801 $1.19 Million
Q4 2019 Feb 05, 2020	BUY	$31.7 - $69.93 $118,526 - $261,468	3,739 Added 16.62%	26,232 $1.63 Million
Q3 2019 Oct 23, 2019	BUY	$19.95 - $38.85 $124,587 - $242,618	6,245 Added 38.44%	22,493 $763,000
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $103,292 - $128,612	4,907 Added 43.27%	16,248 $366,000
Q1 2019 May 01, 2019	SELL	$20.65 - $29.55 $2,581 - $3,693	-125 Reduced 1.09%	11,341 $263,000
Q4 2018 Jan 31, 2019	BUY	$19.08 - $36.14 $76,320 - $144,560	4,000 Added 53.58%	11,466 $241,000
Q3 2018 Nov 07, 2018	SELL	$33.57 - $42.1 $5,874 - $7,367	-175 Reduced 2.29%	7,466 $289,000
Q2 2018 Aug 06, 2018	BUY	$20.06 - $44.95 $153,278 - $343,462	7,641 New	7,641 $301,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account